Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for Ménière's disease
ACTRN12612000053820Phase 2Not yet recruiting
- Sponsor
- Professor William Gibson
- Start
- Apr 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Meniere Disease comparing Valtrex with Placebo (2 arms). Primary endpoint: Frequency of vertigo attacks. Planned start Apr 2012; status: not yet recruiting.
02
Drugs
valaciclovir
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on ACTRN12612000053820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000053820.